Abstract:Abstract Despite the vital activity of many compounds, they lack that effectiveness due to their low solubility in water. Unfortunately, for this reason, rutin often leads to low tissue permeability and insufficient bioavailability, which has greatly limited its pharmacological utility. Therefore, the present investigation is designed to overcome this problem by formulating the rotin to rotin nanocrystals (RNCs) with studying their some pharmacological applications in vitro and in silico. RNCs were created via the ultrasonication approach and showed a spherical shape via Transmission electron microscopy with a mean particle size of 27 nm. RNCs reflected inhibitory action against Helicobacter pylori with an inhibition zone (IZ) of 22.67 mm compared to rutin (IZ of 18 mm) and standard control (IZ of 19.5 mm). RNCs exhibited less minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) (7.8 μg/mL) than rutin (62.5 μg/mL). The MBC/MIC index of rutin and RNCs indicated their bactericidal properties. RNCs were more acutely ( 92.12%) than rutin (85.43%) for inhibition the H. pylori biofilm formation. A promising half maximal inhibitory concentration (IC 50 ) (6.85 μg/mL) was recorded using RNCs for urease inhibition compared to the IC 50 value of rutin (97.8 μg/mL). The activity of rutin and RNCs was tested against cancer cells of human colon cancer (HT-29) and normal Vero cells. IC 50 values of RNCs were less 168.23 ± 1.15 μg/mL and 297.69 ± 4.23 μg/mL than the IC 50 values of rutin 184.96 ± 4.33 μg/mL and 335.31 ± 2.02 μg/mL against HT-29 cells and normal Vero cells, respectively. Different percentages (72.2, 77.3, and 81.9%) of hemolysis inhibition were recorded using RNCs, but 63.6, 68.9, 73.6, and 80.6% were obtained using rutin at 600, 800, and 1000 μg/mL, respectively. Butyrylcholinesterase (BChE) inhibition % was documented at a lower IC 50 value for RNCs (12.74 μg/mL) than the IC 50 of rutin (18.15 μg/mL). The target molecule underwent molecular docking research against H. pylori [Protein Data Bank (PDB) code: 4HI0], HT-29 cells (PDB code: 2HQ6), and BChE (PDB code: 6EMI) in order to enhance the interactions between rutin and the chosen receptors and to estimate its molecular operating environment (MOE) affinity scoring. Rutin has predicted strong binding interactions and potent activity against the examined proteins 4HI0, 2HQ6, and 6EMI with low binding scores of − 7.47778 kcal/mol, − 7.68511 kcal/mol, and − 9.50333 kcal/mol, respectively.

The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man

Studies on drug metabolism by use of isotopes XXVII: urinary metabolites of rutin in rats and the role of intestinal microflora in the metabolism of rutin.

Characterization of the global metabolic profile of liquiritin in rat plasma, urine, bile and feces based on UHPLC-FT-ICR MS

Biotransformation of Rutin in In Vitro Porcine Ileal and Colonic Fermentation Models

Conversion of Rutin, a Prevalent Dietary Flavonol, by the Human Gut Microbiota

Simultaneous collection of the portal and superior vena cava blood in conscious rats defined that intestinal epithelium is the major site of glucuronidation, but not sulfation and methylation, of quercetin

Hydrolysis of the Rutinose-Conjugates Flavonoids Rutin and Hesperidin by the Gut Microbiota and Bifidobacteria

Enzymatic Hydrolysis of Rutin: Evaluation of Kinetic Parameters and Anti-Proliferative, Mutagenic and Anti-Mutagenic Effects

Characterization and Evaluation of the Solubility and Oral Bioavailability of Rutin–Ethanolate Solvate

Simultaneous Determination of Three Flavonoids in Rat Plasma by RP-LC after Oral Administration of the Total Flavonoids of Scutellaria Barbata

Metabolism of rutin and poncirin by human intestinal microbiota and cloning of their metabolizing α-L-rhamnosidase from Bifidobacterium dentium.

Comparative pharmacokinetic interactions of Quercetin and Rutin in rats after oral administration of European patented formulation containing Hipphophae rhamnoides and Co-administration of Quercetin and Rutin

Pharmacokinetics, Tissue Distribution and Excretion of Luteolin and Its Major Metabolites in Rats: Metabolites Predominate in Blood, Tissues and Are Mainly Excreted Via Bile

Intestinal Absorption Kinetics of Rhamnosylvitexin in Rats

Carbon Dioxide Is the Major Metabolite of Quercetin in Humans

Inhibitory potential of rutin and rutin nano-crystals against Helicobacter pylori, colon cancer, hemolysis and Butyrylcholinesterase in vitro and in silico

RUTIN, a widely consumed flavonoid, that commonly induces hormetic effects

Absorption and metabolism of genistein in isolated rat small intestine

The Beneficial Role of Rutin, A Naturally Occurring Flavonoid in Health Promotion and Disease Prevention: A Systematic Review and Update

Dietary Fibres Differentially Impact on the Production of Phenolic Acids from Rutin in an In Vitro Fermentation Model of the Human Gut Microbiota

Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin